Adverum Biotechnologies Stock In The News
| ADVM Stock | USD 4.61 0.11 2.44% |
Our overall analysis of Adverum Biotechnologies' news coverage and content from conventional and social sources shows investors' bearish mood towards Adverum Biotechnologies. The specific impact of Adverum Biotechnologies news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Adverum Biotechnologies' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Adverum Biotechnologies headlines in addition to utilizing other, more conventional financial analysis modules. Check out Adverum Biotechnologies Backtesting and Adverum Biotechnologies Hype Analysis. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
Adverum |
Adverum Biotechnologies Today Top News and Investor Outlook
Adverum Biotechnologies Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Adverum and other traded companies coverage with news coverage. We help investors stay connected with Adverum headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Adverum Stock performance. Please note that trading solely based on the Adverum Biotechnologies hype is not for everyone as timely availability and quick action are needed to avoid losses.
Adverum Biotechnologies stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Adverum earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Adverum Biotechnologies that are available to investors today. That information is available publicly through Adverum media outlets and privately through word of mouth or via Adverum internal channels. However, regardless of the origin, that massive amount of Adverum data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Adverum Biotechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Adverum Biotechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Adverum Biotechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Adverum Biotechnologies alpha.
Adverum Largest EPS Surprises
Earnings surprises can significantly impact Adverum Biotechnologies' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2017-11-08 | 2017-09-30 | -0.29 | -0.32 | -0.03 | 10 | ||
2020-05-28 | 2020-03-31 | -0.27 | -0.31 | -0.04 | 14 | ||
2019-05-08 | 2019-03-31 | -0.27 | -0.23 | 0.04 | 14 | ||
2019-03-06 | 2018-12-31 | -0.29 | -0.25 | 0.04 | 13 | ||
2018-11-08 | 2018-09-30 | -0.3 | -0.26 | 0.04 | 13 | ||
2022-11-10 | 2022-09-30 | -0.34 | -0.4 | -0.06 | 17 |
Adverum Biotechnologies Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Adverum Biotechnologies Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
4th of March 2025
Oppenheimer maintains Outperform on Adverum stock, 32 target - Investing.com at news.google.com
28th of February 2025
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635 at globenewswire.com
25th of February 2025
How Is Adverum Biotechnologies Positioned in the Gene Therapy Sector at kalkinemedia.com
5th of February 2025
Adverum Biotechnologies to Participate in the Oppenheimer 35th Annual Healthcare Life Scie... at gurufocus.com
15th of January 2025
Adverum Biotechnologies stock hits 52-week low at 4.4 By Investing.com - Investing.com Nig... at news.google.com
23rd of December 2024
Adverum Biotechnologies stock hits 52-week low at 4.61 - Investing.com at news.google.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adverum Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adverum Biotechnologies' short interest history, or implied volatility extrapolated from Adverum Biotechnologies options trading.
Check out Adverum Biotechnologies Backtesting and Adverum Biotechnologies Hype Analysis. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.95) | Revenue Per Share | Quarterly Revenue Growth (0.70) | Return On Assets | Return On Equity |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.